Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Birgit Weynand and Suzanne Kaptein.
Birgit Weynand
Connection Strength
0.518
Suzanne Kaptein
  1. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26955-26965.
    View in: PubMed
    Score: 0.227
  2. Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens". EBioMedicine. 2021 Jul; 69:103454.
    View in: PubMed
    Score: 0.060
  3. Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters. EBioMedicine. 2021 Jun; 68:103403.
    View in: PubMed
    Score: 0.059
  4. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine. 2021 Apr; 66:103288.
    View in: PubMed
    Score: 0.058
  5. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Nature. 2021 02; 590(7845):320-325.
    View in: PubMed
    Score: 0.057
  6. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat Commun. 2020 11 17; 11(1):5838.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.